Buy this Medical Sector Pioneer Stock

01:33pm, Tuesday, 22'nd Nov 2022
Gilead Sciences (GILD) is up roughly 20% since its Q3 release in October, let's take a look at what could continue propelling GILD stock.
Stocks that are killed in a given year often come back to life the following year, especially in January.

Pfizer (PFE), BioNTech Provide New Data on BA.4/BA.5 Boosters

10:35am, Monday, 21'st Nov 2022 Zacks Investment Research
Pfizer (PFE) and BioNTech's (BNTX) Omicron BA.4/BA.5-adapted bivalent vaccines show improved immune response against newer Omicron sublineages.

Got $500? 3 Growth Stocks to Buy That Could Double Your Money

11:30am, Sunday, 20'th Nov 2022 The Motley Fool
Innovative products and services could keep these companies growing.
Innovative products and services could keep these companies growing.

These Wildly Undervalued Stocks Could Go Parabolic

11:00am, Saturday, 19'th Nov 2022 The Motley Fool
These stocks could be heading for a big recovery.
Moderna's researchers say the current vaccine may be less effective against the South African Covid strain. They are planning to test a booster shot vaccine and develop a new vaccine to target Covid v

Final Trades: Boeing, Moderna, Melco & more

03:31am, Saturday, 19'th Nov 2022
The "Halftime Report" traders give their top picks to watch for the second half.

2 Concerning Trends That Make Moderna a Risky Buy

02:00pm, Thursday, 17'th Nov 2022 The Motley Fool
Investors should expect this to be a volatile stock for the foreseeable future.

The Zacks Analyst Blog Highlights Merrimack Pharmaceuticals, Moderna and Seagen

11:56am, Thursday, 17'th Nov 2022 Zacks Investment Research
Highlights Merrimack Pharmaceuticals, Moderna and Seagen are included in this Analyst Blog.

3 Stocks I'm Planning to Buy Very Soon

11:32am, Thursday, 17'th Nov 2022 The Motley Fool
I don't own these three stocks yet, but they all have massive potential and trade for steep discounts.

Biotech Stock Roundup: MACK Up on Study Data, MRNA Offers Vaccine Update & More

04:28pm, Wednesday, 16'th Nov 2022 Zacks Investment Research
Pipeline updates from MACK and MRNA are the key highlights from the biotech sector during the past week.
Moderna, Inc. (NASDAQ:MRNA ) 13th Annual Jefferies London Healthcare Conference 2022 Call November 15, 2022 10:50 AM ET Company Participants Stephen Hoge - President Conference Call Participants Micha

Moderna's (MRNA) Omicron BA.4/5 Booster Jab Study Meets Goal

09:16pm, Tuesday, 15'th Nov 2022 Zacks Investment Research
Moderna's (MRNA) Omicron-targeting bivalent COVID vaccines exhibit substantial antibody response compared with an original booster dose of Spikevax.
Moderna's (MRNA) Omicron-targeting bivalent COVID vaccines exhibit substantial antibody response compared with an original booster dose of Spikevax.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE